These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 32310052

  • 1. Novel Conjugated Quinazolinone-Based Hydroxamic Acids: Design, Synthesis and Biological Evaluation.
    Vu TK, Thanh NT, Minh NV, Linh NH, Thao NTP, Nguyen TTB, Hien DT, Chinh LV, Duc TH, Anh LD, Hai PT.
    Med Chem; 2021; 17(7):732-749. PubMed ID: 32310052
    [Abstract] [Full Text] [Related]

  • 2. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
    Minh NV, Thanh NT, Lien HT, Anh DTP, Cuong HD, Nam NH, Hai PT, Minh-Ngoc L, Le-Thi-Thu H, Chinh LV, Vu TK.
    Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
    [Abstract] [Full Text] [Related]

  • 3. Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
    Hieu DT, Anh DT, Hai PT, Thuan NT, Huong LT, Park EJ, Young Ji A, Soon Kang J, Phuong Dung PT, Han SB, Nam NH.
    Chem Biodivers; 2019 Apr; 16(4):e1800502. PubMed ID: 30653817
    [Abstract] [Full Text] [Related]

  • 4. Design, Synthesis and Evaluation of Novel 3/4-((Substituted benzamidophenoxy) methyl)-N-hydroxybenzamides/propenamides as Histone Deacetylase Inhibitors and Antitumor Agents.
    Anh DT, Thuan NT, Hai PT, Huong LT, Yen NTK, Han BW, Park EJ, Choi YJ, Kang JS, Hue VTM, Han SB, Nam NH.
    Anticancer Agents Med Chem; 2019 Apr; 19(4):546-556. PubMed ID: 30426904
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents.
    Hieu DT, Anh DT, Tuan NM, Hai PT, Huong LT, Kim J, Kang JS, Vu TK, Dung PTP, Han SB, Nam NH, Hoa ND.
    Bioorg Chem; 2018 Feb; 76():258-267. PubMed ID: 29223029
    [Abstract] [Full Text] [Related]

  • 6. Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
    Hieu DT, Anh DT, Hai PT, Huong LT, Park EJ, Choi JE, Kang JS, Dung PTP, Han SB, Nam NH.
    Chem Biodivers; 2018 Jun; 15(6):e1800027. PubMed ID: 29667768
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents.
    Anh DT, Hai PT, Dung DTM, Dung PTP, Huong LT, Park EJ, Jun HW, Kang JS, Kwon JH, Tung TT, Han SB, Nam NH.
    Bioorg Med Chem Lett; 2020 Nov 15; 30(22):127537. PubMed ID: 32916298
    [Abstract] [Full Text] [Related]

  • 8. 5-aryl-1,3,4-thiadiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents: synthesis, bioevaluation and docking study.
    Huong TT, Dung do TM, Oanh DT, Lan TT, Dung PT, Loi VD, Kim KR, Han BW, Yun J, Kang JS, Kim Y, Han SB, Nam NH.
    Med Chem; 2015 Nov 15; 11(3):296-304. PubMed ID: 25256241
    [Abstract] [Full Text] [Related]

  • 9. Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis.
    Dung DTM, Huan NV, Cam DM, Hieu DC, Hai PT, Huong LT, Kim J, Choi JE, Kang JS, Han SB, Nam NH.
    Med Chem; 2018 Nov 15; 14(8):831-850. PubMed ID: 29807520
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
    Xie R, Yao Y, Tang P, Chen G, Liu X, Yun F, Cheng C, Wu X, Yuan Q.
    Eur J Med Chem; 2017 Jul 07; 134():1-12. PubMed ID: 28391133
    [Abstract] [Full Text] [Related]

  • 11. Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity.
    Huong TT, Dung DT, Huan NV, Cuong LV, Hai PT, Huong LT, Kim J, Kim YG, Han SB, Nam NH.
    Bioorg Chem; 2017 Apr 07; 71():160-169. PubMed ID: 28196602
    [Abstract] [Full Text] [Related]

  • 12. Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as histone deacetylase inhibitors and antitumor agents.
    Dung do TM, Dung PT, Oanh DT, Hai PT, Huong le TT, Loi VD, Hahn H, Han BW, Kim J, Han SB, Nam NH.
    Med Chem; 2015 Apr 07; 11(8):725-35. PubMed ID: 26133355
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors.
    Chen J, Li D, Li W, Yin J, Zhang Y, Yuan Z, Gao C, Liu F, Jiang Y.
    Bioorg Med Chem; 2018 Aug 07; 26(14):3958-3966. PubMed ID: 29954683
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton.
    Ha VT, Kien VT, Binh le H, Tien VD, My NT, Nam NH, Baltas M, Hahn H, Han BW, Thao do T, Vu TK.
    Bioorg Chem; 2016 Jun 07; 66():63-71. PubMed ID: 27018835
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.
    Yuan Z, Sun Q, Li D, Miao S, Chen S, Song L, Gao C, Chen Y, Tan C, Jiang Y.
    Eur J Med Chem; 2017 Jul 07; 134():281-292. PubMed ID: 28419930
    [Abstract] [Full Text] [Related]

  • 16. Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities.
    Yang F, Zhao N, Song J, Zhu K, Jiang CS, Shan P, Zhang H.
    Molecules; 2019 Jul 15; 24(14):. PubMed ID: 31311163
    [Abstract] [Full Text] [Related]

  • 17. New benzothiazole/thiazole-containing hydroxamic acids as potent histone deacetylase inhibitors and antitumor agents.
    Tung TT, Oanh DT, Dung PT, Hue VT, Park SH, Han BW, Kim Y, Hong JT, Han SB, Nam NH.
    Med Chem; 2013 Dec 15; 9(8):1051-7. PubMed ID: 23521008
    [Abstract] [Full Text] [Related]

  • 18. Novel isatin-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
    Nam NH, Huong TL, Dung do TM, Dung PT, Oanh DT, Quyen D, Thao le T, Park SH, Kim KR, Han BW, Yun J, Kang JS, Kim Y, Han SB.
    Eur J Med Chem; 2013 Dec 15; 70():477-86. PubMed ID: 24185378
    [Abstract] [Full Text] [Related]

  • 19. Exploration of certain 1,3-oxazole- and 1,3-thiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
    Anh DT, Hai PT, Huong LT, Park EJ, Jun HW, Kang JS, Kwon JH, Dung DTM, Anh VT, Hue VTM, Han SB, Nam NH.
    Bioorg Chem; 2020 Aug 15; 101():103988. PubMed ID: 32534346
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
    Guan P, Sun F, Hou X, Wang F, Yi F, Xu W, Fang H.
    Bioorg Med Chem; 2012 Jun 15; 20(12):3865-72. PubMed ID: 22579621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.